ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974

Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too

September 24, 2010

Upton Says NCI Must Take “Vigorous Role” In Prevention

February 3, 1978

Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings

August 7, 1998

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975